Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.17 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Methylnitrosourea |
3.13 | 15113128 15688392 |
MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
7.01 | 3712494 |
MESH:D000236 |
Adenoma |
|
Methylcholanthrene |
7.01 | 6695378 10545420 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
3.56 | 16434500 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.80 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
5.00 | 17306315 16712894 |
MESH:D000690 |
Amyotrophic Lateral Sclerosis |
|
4-hydroxy-2-nonenal |
4.13 | 10965797 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.94 | 10982225 |
MESH:D050197 |
Atherosclerosis |
|
Methylcholanthrene |
3.48 | 11922910 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.41 | 18445737 |
MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
5.12 | 1440618 11289319 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
3.20 | 19483382 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
3.92 | 11985600 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
2.07 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
Calcitriol |
2.07 | 11237771 |
MESH:D001943 |
Breast Neoplasms |
|
Methylcholanthrene |
2.07 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Methylnitrosourea |
2.07 | 11306469 14633655 16253758 |
MESH:D002277 |
Carcinoma |
|
Methylcholanthrene |
4.01 | 10545420 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
4.58 | 7296757 3581430 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
4.58 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
4.58 | 17306315 15276417 16507464 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
5.07 | 17123778 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
2.70 | 7296757 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Calcitriol |
4.86 | 11237771 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
4.86 | 18572023 |
MESH:D006332 |
Cardiomegaly |
|
valsartan |
4.21 | 19597038 |
MESH:D009202 |
Cardiomyopathies |
|
valsartan |
4.47 | 16247790 |
MESH:D002318 |
Cardiovascular Diseases |
|
Hydrogen Peroxide |
8.02 | 16936243 |
MESH:D002318 |
Cardiovascular Diseases |
|
valsartan |
8.02 | 11230374 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
7.66 | 10977129 |
MESH:D002386 |
Cataract |
|
Methylnitrosourea |
7.66 | 12484553 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
21.53 | 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
21.53 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Methylcholanthrene |
21.53 | 16192471 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Methylnitrosourea |
21.53 | 2727394 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
21.53 | 20056578 19524636 |
MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
13.62 | 19486331 9022650 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
13.62 | 19486331 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
13.62 | 19176532 |
MESH:D002971 |
Cleft Lip |
marker/mechanism |
|
| 17576140 |
MESH:D002972 |
Cleft Palate |
marker/mechanism |
|
| 17576140 |
MESH:D003324 |
Coronary Artery Disease |
|
valsartan |
3.91 | 17719468 |
MESH:D003384 |
Coxsackievirus Infections |
|
valsartan |
5.92 | 20392896 |
MESH:D019465 |
Craniofacial Abnormalities |
marker/mechanism |
|
| 17576140 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
2.87 | 8156756 18759878 2524372 14531868 12868966 11298694 11906362 8970840 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.45 | 18249437 |
MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
3.55 | 2952479 3621924 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
valsartan |
4.64 | 11508273 |
MESH:D058065 |
Diabetic Cardiomyopathies |
|
Taurine |
6.13 | 16025228 |
MESH:D003928 |
Diabetic Nephropathies |
|
valsartan |
4.84 | 18630688 11427623 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
6.47 | 18692083 1440618 9022650 18289764 6482804 7440962 9328219 16192314 8291058 6679447 9653073 18648102 11289319 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
6.47 | 10663392 12958197 12705907 16177239 12594235 16227642 12153990 17522070 14550746 15968718 19164858 11421492 12540782 11834606 18071297 10915739 19416960 19085960 16393943 12392966 11739529 19420014 16781746 16109766 11461765 15619225 16485898 16081117 11529661 14986274 18713872 14725611 17562736 11743745 19370779 19923254 17906064 2444490 19739265 11287661 10774834 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Taurine |
6.47 | 9328219 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
4.19 | 19426721 |
MESH:D004487 |
Edema |
|
pirinixic acid |
2.53 | 12083418 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Calcitriol |
4.00 | 15138306 |
MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
2.12 | 3581430 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
7.74 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
7.74 | 20131406 19236843 |
MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
5.12 | 6705139 |
MESH:D005354 |
Fibrosarcoma |
|
Methylcholanthrene |
12.50 | 14633661 10962813 |
MESH:D005354 |
Fibrosarcoma |
|
Methylnitrosourea |
12.50 | 11555667 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
9.39 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
valsartan |
9.39 | 16893502 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.77 | 16983495 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.76 | 16452187 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.30 | 8708960 |
MESH:D005910 |
Glioma |
|
Methylnitrosourea |
3.58 | 9825942 |
MESH:D015432 |
Glomerulonephritis, Membranoproliferative |
|
valsartan |
5.61 | 16928621 |
MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
4.10 | 7505956 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
7.49 | 20558911 |
MESH:D006333 |
Heart Failure |
|
valsartan |
7.49 | 19027736 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.50 | 15720958 |
MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
3.58 | 6705139 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
3.07 | 18467677 19772884 19176532 16221962 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
3.20 | 12676792 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
2.74 | 16870215 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.23 | 20558911 |
MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
4.01 | 15034207 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
5.68 | 10903974 |
MESH:D006973 |
Hypertension |
|
valsartan |
5.68 | 18344623 10903974 20102058 16475468 11427623 12850387 12692753 18390891 |
MESH:D006974 |
Hypertension, Malignant |
|
valsartan |
6.51 | 11560862 |
MESH:D007248 |
Infertility, Male |
|
Methylnitrosourea |
7.24 | 7193160 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
7.24 | 12646999 15346721 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
7.43 | 16393666 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
7.43 | 16306350 |
MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
5.12 | 8074119 9022650 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.54 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
14.74 | 12587719 15629191 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
14.74 | 8314463 10903974 18776723 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
14.74 | 20008137 |
MESH:D007674 |
Kidney Diseases |
|
valsartan |
14.74 | 10903974 12164870 16893502 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Hydrogen Peroxide |
4.33 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
7.42 | 6582329 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
7.42 | 12371664 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Methylnitrosourea |
4.24 | 15526292 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
3.23 | 9327722 15034207 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
3.87 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Taurine |
3.87 | 15931870 15893842 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
valsartan |
3.87 | 15619341 16872305 15504291 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
1.64 | 12969438 16610002 12587719 19784758 16611625 11587558 19014921 19460945 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.29 | 17185352 16871587 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
4.55 | 15890375 20007298 16377806 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
4.55 | 16712894 15276417 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
6.27 | 3712494 6587162 1399818 598648 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Methylcholanthrene |
6.27 | 1399818 598648 |
MESH:D038061 |
Lower Extremity Deformities, Congenital |
|
Methylnitrosourea |
5.54 | 16080182 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
3.21 | 19095001 |
MESH:D055370 |
Lung Injury |
|
Asbestos, Crocidolite |
4.09 | 17365036 |
MESH:D008175 |
Lung Neoplasms |
marker/mechanism |
|
| 15136453 |
MESH:D008175 |
Lung Neoplasms |
|
Methylcholanthrene |
3.71 | 16271038 21163286 20970405 1399818 15390079 9230183 17909032 16337739 20512841 7750092 10545420 6695378 11893704 |
MESH:D008175 |
Lung Neoplasms |
|
Methylnitrosourea |
3.71 | 18062963 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
3.71 | 19931552 16712894 17306315 17077188 15276417 |
MESH:D008223 |
Lymphoma |
|
Methylnitrosourea |
4.05 | 11418001 16257854 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Methylnitrosourea |
4.83 | 14633661 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Methylnitrosourea |
3.61 | 12931682 16944150 17020996 15688392 19196723 11751437 16619500 15313902 10838139 11807958 10767621 14999141 16051031 15113128 16827153 14633655 17131329 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
2.04 | 16487513 19082730 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.64 | 19513568 |
MESH:D008654 |
Mesothelioma |
|
Asbestos, Crocidolite |
3.20 | 18303189 16966607 16166281 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.88 | 16801185 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.58 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.16 | 19151258 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
2.99 | 16411023 |
MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
2.49 | 3581430 |
MESH:D009369 |
Neoplasms |
|
Methylnitrosourea |
8.51 | 15533788 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
8.51 | 17405874 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
8.51 | 11559025 |
MESH:D009374 |
Neoplasms, Experimental |
|
Methylnitrosourea |
9.64 | 12696579 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
9.64 | 20056578 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.54 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.33 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
4.04 | 11399458 16427766 |
MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
7.37 | 6679447 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
7.37 | 12854658 |
MESH:D009442 |
Neurilemmoma |
|
Methylnitrosourea |
5.57 | 11555667 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
2.91 | 18514411 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.82 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
3.47 | 6482804 4026338 |
MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
5.12 | 3988306 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
5.07 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
2.45 | 17306315 15276417 |
MESH:D010146 |
Pain |
|
Acetaminophen |
2.43 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Methylnitrosourea |
3.38 | 16965848 |
MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
9.56 | 7296757 |
MESH:D010212 |
Papilloma |
|
Hydrogen Peroxide |
9.56 | 12065085 |
MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
13.32 | 6228378 |
MESH:D010787 |
Photosensitivity Disorders |
|
4-hydroxy-2-nonenal |
13.32 | 11550810 |
MESH:D010995 |
Pleural Diseases |
|
Asbestos, Crocidolite |
4.96 | 10923243 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.27 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
4.03 | 10548101 |
MESH:D011470 |
Prostatic Hyperplasia |
|
Calcitriol |
4.86 | 15572423 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
4.26 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
2.14 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Calcitriol |
2.14 | 18247401 16289102 12479363 16644109 15754350 |
MESH:D011471 |
Prostatic Neoplasms |
|
Methylnitrosourea |
2.14 | 15682402 12376480 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
2.14 | 16039940 |
MESH:D011507 |
Proteinuria |
|
valsartan |
4.91 | 17664856 12164870 18344623 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.24 | 16882103 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.87 | 10548101 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Asbestos, Crocidolite |
6.30 | 17365031 15814490 17975199 17322281 |
MESH:D011658 |
Pulmonary Fibrosis |
|
valsartan |
6.30 | 17241526 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.41 | 19058328 |
MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
9.25 | 3692021 |
MESH:D012162 |
Retinal Degeneration |
|
Methylnitrosourea |
9.25 | 18155124 18172121 |
MESH:D012175 |
Retinoblastoma |
|
Methylnitrosourea |
5.57 | 11555667 |
MESH:D012878 |
Skin Neoplasms |
|
Hydrogen Peroxide |
6.05 | 12065085 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
6.05 | 19524636 18572023 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.84 | 12854658 |
MESH:D013274 |
Stomach Neoplasms |
|
Methylnitrosourea |
2.69 | 15930296 16257854 18593901 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
4.07 | 16684133 16045194 |
MESH:D013953 |
Thymus Neoplasms |
|
Methylnitrosourea |
5.31 | 11418001 |
MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
7.60 | 1399818 7505956 3712494 6587162 6582329 |
MESH:D013964 |
Thyroid Neoplasms |
|
Methylnitrosourea |
7.60 | 3078959 7505956 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
5.15 | 8074119 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
5.15 | 16712894 17306315 11723127 16452187 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
3.03 | 10982225 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
3.82 | 11813266 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
5.11 | 14652134 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.08 | 1336536 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.51 | 17056641 |
MESH:D020257 |
Ventricular Remodeling |
|
valsartan |
5.78 | 19027736 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.54 | 17120751 |